Innovative Medicines Initiative 2 (IMI2) Joint Undertaking

This procedure concerns the establishment of the Innovative Medicines Initiative 2 Joint Undertaking. It aims to foster collaboration between public and private sectors to accelerate the development of new medicines and treatments.

This initiative affects the pharmaceutical industry, research institutions, and patients by promoting faster access to innovative healthcare solutions and strengthening Europe's research capacity.